Award-winning journalist Richard Harris has reported on a wide range of topics in science, medicine and the environment since he joined NPR in 1986. In early 2014, his focus shifted from an emphasis on climate change and the environment to biomedical research.
Harris has traveled to all seven continents for NPR. His reports have originated from Timbuktu, the South Pole, the Galapagos Islands, Beijing during the SARS epidemic, the center of Greenland, the Amazon rain forest, the foot of Mt. Kilimanjaro (for a story about tuberculosis), and Japan to cover the nuclear aftermath of the 2011 tsunami.
In 2010, Harris' reporting revealed that the blown-out BP oil well in the Gulf of Mexico was spewing out far more oil than asserted in the official estimates. That revelation led the federal government to make a more realistic assessment of the extent of the spill.
Harris covered climate change for decades. He reported from the United Nations climate negotiations, starting with the Earth Summit in Rio de Janeiro in 1992, and including Kyoto in 1997 and Copenhagen in 2009. Harris was a major contributor to NPR's award-winning 2007-2008 "Climate Connections" series.
Over the course of his career, Harris has been the recipient of many prestigious awards. Those include the American Geophysical Union's 2013 Presidential Citation for Science and Society. He shared the 2009 National Academy of Sciences Communication Award and was a finalist again in 2011. In 2002, Harris was elected an honorary member of Sigma Xi, the scientific research society. Harris shared a 1995 Peabody Award for investigative reporting on NPR about the tobacco industry. Since 1988, the American Association for the Advancement of Science has honored Harris three times with its science journalism award.
Before joining NPR, Harris was a science writer for the San Francisco Examiner. From 1981 to 1983, Harris was a staff writer at The Tri-Valley Herald in Livermore, California, covering science, technology, and health issues related to the nuclear weapons lab in Livermore. He started his career as an AAAS Mass Media Science Fellow at the now-defunct Washington Star in DC.
Harris is co-founder of the Washington, DC, Area Science Writers Association, and is past president of the National Association of Science Writers. He serves on the board of the Council for the Advancement of Science Writing.
Harris' book Rigor Mortis was published in 2017. The book covers the biomedicine "reproducibility crisis" — many studies can't be reproduced in other labs, often due to lack of rigor, hence the book's title. Rigor Mortis was a finalist for the 2018 National Academy of Sciences/Keck Communication Award.
A California native, Harris returned to the University of California-Santa Cruz in 2012, to give a commencement address at Crown College, where he had given a valedictory address at his own graduation. He earned a bachelor's degree at the school in biology, with highest honors.
President Trump and administration officials announced an expansion of a ban on travel from Europe to include the U.K. and Ireland.
There's still a big gap between what the federal government is promising in terms of testing capacity in the U.S. and what state and local labs can deliver.
Researchers in Asia are using a blood test that identifies people who have previously been exposed to the new coronavirus. In the U.S., that kind of test isn't yet available.
The coronavirus that emerged in China late last year has now been detected in at least 56 nations. The rapid spread drove down stock markets.
The COVID-19 virus has spread in Asia, North America, Europe and the Middle East, but the World Health Organization is holding off on calling it a pandemic, at least for now.
The new coronavirus disease has been diagnosed in 28 countries, and new outbreaks are worrisome. But the World Health Organization sees some encouraging trends.
Health officials say the cases increased in China's Hubei province. That comes as scientists there have changed the definition of who has the disease know as COVID-19.
They're testing some drugs developed for other diseases. And they're offering supportive care — doing whatever's possible to keep vital organ systems functioning.
Does the virus have an official name yet? Can I get the disease from touching goods shipped from China? How worried should we be in the U.S.? We answer questions from our readers.
With cases growing quickly abroad, the federal government announced several measures to prevent the new coronavirus from taking hold in the U.S.